Publication | Open Access
Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.
57
Citations
29
References
1987
Year
Viral PathogenesisImmunologyImmunotherapyHuman RetrovirusSynthetic PeptideViral GeneticsAllergyVirologyAutoimmunityCell BiologyMolecular VirologyPathogenesisAntiviral ResponseFeline Leukemia VirusOncogenic RetrovirusesImmunoglobulin EImmunoglobulin SynthesisMedicineViral OncologySuppressive Effect
Purified feline leukemia virus, UV light-inactivated feline leukemia virus, and a synthetic peptide (CKS-17) homologous to a well-conserved region of the transmembrane components of several human and animal retroviruses were each studied for their effects on IgG production by feline peripheral blood lymphocytes. Using a reverse hemolytic plaque assay, both the viable virus and the UV-inactivated feline leukemia virus, but not the CKS-17, activated B lymphocytes to secrete IgG. When staphylococcal protein A, a polyclonal B-cell activator, was used to stimulate IgG synthesis by feline lymphocytes, the viable virus, the UV-inactivated virus, and the CKS-17 peptide each strongly suppressed IgG secretion without compromising viability of the lymphocytes. These findings suggest that the immunosuppressive influences of feline leukemia virus on immunoglobulin synthesis may reside in a conserved portion of the envelope glycoprotein that includes the region homologous to CKS-17.
| Year | Citations | |
|---|---|---|
Page 1
Page 1